Cerner Corp (NASDAQ:CERN), a global healthcare technology company, stock rose 0.19% (As on Apr 12, 2:08:50 AM UTC-4, Source: Google Finance) after Argus Research downgraded the previous rating of Buy to Hold.

On the other hand, On Dec. 20, 2021, the company had entered into an Agreement and Plan of Merger (as it may be amended or supplemented from time to time, the “Merger Agreement”) with Cedar Acquisition Corporation (“Merger Subsidiary”), OC Acquisition LLC and Oracle Corporation (“Oracle”). Pursuant to the Merger Agreement, on Jan. 19, 2022, Oracle commenced a cash tender offer (the “Offer”) to acquire all of the issued and outstanding shares of our common stock, par value $0.01 per share (the “Shares”) for a purchase price of $95.00 per share, net to the holders thereof in cash, without interest and subject to any required tax withholding. Following the completion of the Offer, Merger Subsidiary will merge with and into Cerner (the “Merger”), with Cerner continuing as the surviving corporation and as a wholly owned indirect subsidiary of Oracle, at which time the Shares would cease to be publicly held. We expect the Merger to close in calendar year 2022, subject to receiving certain regulatory approvals and satisfying other closing conditions, including Cerner stockholders tendering a majority of Cerner’s outstanding Shares in the Offer.

Meanwhile, for the fourth quarter, revenue was of $1.452 billion, up 4% compared to $1.395 billion in the fourth quarter of 2020. Adjusted Operating Margin (non-GAAP) was of 23.0%, up 150 basis points from 21.5% in year-ago quarter. Adjusted Diluted EPS (non-GAAP) of $0.93, up 19% compared to $0.78 in year-ago quarter. The company generated GAAP cash flow from operating activities of $517 million, up 1% compared to $513 million in year-ago quarter. Free Cash Flow (non-GAAP) of $409 million, up 3% compared to $396 million in the year-ago quarter. For the full year the company delivered solid revenue growth, expanded Adjusted Operating Margin (non-GAAP) by 180 basis points, increased Adjusted Diluted EPS (non-GAAP) by 18% and generated record GAAP cash flow from operating activities of $1.772 billion and Free Cash Flow (Non-GAAP) of $1.174 billion, which were up 23% and 37%, respectively, over 2020

Additionally, the company has declared a cash dividend to stockholders of $0.27 per issued and outstanding share. The cash dividend will be payable April 19, 2022, to shareholders of record as of the close of business March 28, 2022.